Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Allarity Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −1 vs. Q4 2025
- Shares held
- 950.6K
- −94.8K (−9.1%) vs. Q4 2025
- Total value
- $1.04M
- −$92.7K (−8.2%) vs. Q4 2025
- New holders
- 5
- 2 more added
- Sold out
- 6
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $1.65M |
| Q1 2026 | 14 | $1.04M |
| Q4 2025 | 16 | $1.40M |
| Q3 2025 | 11 | $1.63M |
| Q2 2025 | 10 | $197.0K |
| Q1 2025 | 9 | $86.5K |
| Q4 2024 | 6 | $122.3K |
| Q3 2024 | 4 | $46.2K |
| Q2 2024 | 9 | $107.8K |
| Q1 2024 | 4 | $11.7K |
| Q4 2023 | 4 | $31.8K |
| Q3 2023 | 7 | $515.6K |
| Q2 2023 | 4 | $33.3K |
| Q1 2023 | 6 | $4.05K |
| Q4 2022 | 10 | $42.0K |
| Q3 2022 | 10 | $181.0K |
| Q2 2022 | 10 | $304.0K |
| Q1 2022 | 10 | $694.0K |
| Q4 2021 | 3 | $270.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Allarity Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 228,084 | $248.6K | 0.00% | −19,528−7.9% | Reduced |
| Geode Capital Management, LLC | 190,393 | $207.5K | 0.00% | +33,753+21.5% | Added |
| Vanguard Capital Management LLC | 171,795 | $187.3K | 0.00% | +171,795 | New |
| State Street Corp | 137,600 | $150.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 74,913 | $81.7K | 0.00% | +74,913 | New |
| Northern Trust Corp | 48,103 | $52.4K | 0.00% | +19,161+66.2% | Added |
| XTX Topco Ltd | 28,967 | $31.6K | 0.00% | −4,677−13.9% | Reduced |
| Two Sigma Investments, LP | 27,492 | $30.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 23,158 | $25.2K | 0.00% | −3,358−12.7% | Reduced |
| Two Sigma Securities, LLC | 12,334 | $13.4K | 0.00% | −1,260−9.3% | Reduced |
| Citigroup Inc | 7,766 | $8.46K | 0.00% | +7,766 | New |
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1 | $1 | 0.00% | +1 | New |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| DRW Securities, LLC | 0 | $0 | 0.00% | −122,741−100.0% | Sold out |
| Capital Advisors Inc | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −84,591−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −55,536−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,347−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |